[Skip to Content]
[Skip to Content Landing]
September 18, 2002

Testing for Human Papillomavirus in Women With Abnormal Pap Smear Results

Author Affiliations

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2002;288(11):1350. doi:10.1001/jama.288.11.1350

To the Editor: The new Bethesda Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities, which were described by Dr Wright and Colleagues,1 strongly endorse human papillomavirus (HPV) testing for women with atypical squamous cells of uncertain significance (ASC-US). This protocol may lead to a heightened public awareness that cytological abnormalities are caused by a sexually transmitted infection. While HPV testing is partly justified by a desire to reduce the discomfort and anxiety associated with colposcopy, testing may lead to stigma and shame and considerably increase the psychological burden of cervical screening on women, which could ultimately reduce the advances made in cervical cancer prevention.

First Page Preview View Large
First page PDF preview
First page PDF preview